
Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC)
Keywords: سیس پلاتین; Cis; cisplatin; CT; chemotherapy; ECOG; Eastern Cooperative Oncology Group; ESMO; European Society for Medical Oncology; G; grade; GTV; gross tumor volume; CTV; clinical target volume; Pem; pemetrexed; PS; performance status; PTV; planning target volume;